Global Human Albumin research

Human Albumin Comprehensive Study by Type (Human Serum Albumin, Recombinant Serum Albumin), Application (Drug Delivery, Therapeutics, Culture Media, Vaccine Ingredient, Others), End-User (Pharmaceutical & Biotechnology Industries, Research Institutes, Others) Players and Region - Global Market Outlook to 2030

Human Albumin Market by XX Submarkets | Forecast Years 2024-2030 | CAGR: 6.2%  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
Industry Background:
Albumin is a type of protein produced by the liver, which is present in the blood. Human serum albumin are albumins obtained from human plasma. Recombinant albumin is manufactured using recombinant techniques in bacteria & viruses. The albumins are a family of globular proteins. The most albumins are the serum albumins. Albumin family proteins are water-soluble, moderately soluble in concentrated salt solutions, & experience heat denaturation. Albumins are usually found in blood plasma & differ from other blood proteins in that they are not glycosylated.

AttributesDetails
Study Period2018-2030
Base Year2023
UnitValue (USD Million)
Key Companies ProfiledOctapharma AG (Switzerland), CSL Behring LLC (United States), Baxter International, Inc. (United States), MedxBio Pte. Ltd. (Singapore), Novozymes A/S. (Denmark), Mitsubishi Tanabe Pharma Corporation (Japan), Sigma-Aldrich Corporation (United States), China Biologic Products Inc. (China), Thermo Fisher Scientific (United States) and InVitria (United States)


According to AMA, the market for Human Albumin is expected to register a CAGR of 6.2% during the forecast period to 2030. This growth is primarily driven by Increasing Production of Immunoglobulins, High Demand for Albumin in R&D Activities and Increasing Plasma Collection.

Globally, a noticeable market trend is evident Increasing Non-Therapeutic Application of Albumin The Pharmaceuticals sector in the Asia-Pacific region has been increasing at a sustainable rate, and further growth is expected to be witnessed over the forecast period, owing to the robust investments and expansion in production facilities in the region. Major Players, such as Octapharma AG (Switzerland), CSL Behring LLC (United States), Baxter International, Inc. (United States), MedxBio Pte. Ltd. (Singapore), Novozymes A/S. (Denmark), Mitsubishi Tanabe Pharma Corporation (Japan), Sigma-Aldrich Corporation (United States), China Biologic Products Inc. (China), Thermo Fisher Scientific (United States) and InVitria (United States), etc have either set up their manufacturing facilities or are planning to start new provision in the dominated region in the upcoming years. The global market is highly competitive and consists of a limited number of providers competing. The intense competition, changing consumer spending patterns, demographic trends, and frequent changes in consumer preferences pose significant opportunities for market growth.

Key Developments in the Market:
In January 2020, Takeda Pharmaceutical Company Limited has announced the completion of its acquisition of Shire plc. Values-based, R&D-driven biopharmaceutical company.
In March 2021, Albumedix Ltd. announced a distribution agreement with FUJIFILM Wako Pure Chemical Corporation for the Japanese and Chinese markets, including Hong Kong. This partnership aims to address the shortage of high-quality and consistent human albumin in these regions.

Influencing Trend:
Increasing Non-Therapeutic Application of Albumin

Market Growth Drivers:
Increasing Production of Immunoglobulins, High Demand for Albumin in R&D Activities and Increasing Plasma Collection

Challenges:
Pricing Pressure Met By Key Players in the Market and High Competition from Substitute Products

Restraints:
Irrational Uses & Hostile Reactions Related With Albumin and Strict Regulations

Opportunities:
Increasing Applications of Albumin and Emphasis on Emerging Regions to Offer Immense Potential

AMA Research follows a focused and realistic research framework that provides the ability to study the crucial market dynamics in several regions across the world. Moreover, an in-depth assessment is mostly conducted by our analysts on geographical regions to provide clients and businesses the opportunity to dominate in niche markets and expand in emerging markets across the globe. This market research study also showcases the spontaneously changing Players landscape impacting the growth of the market. Furthermore, our market researchers extensively analyze the products and services offered by multiple players competing to increase their market share and presence.

Customization in the Report
AMA Research features not only specific market forecasts but also includes significant value-added commentary on:
- Market Trends
- Technological Trends and Innovations
- Market Maturity Indicators
- Growth Drivers and Constraints in Human Albumin Market
- Analysis about New Entrants in Human Albumin Market & Entry/Exit Barriers
- To Seize Powerful Market Opportunities
- Identify Key Business Segments, Market Proposition & Gap Analysis
- An Unbiased Perspective towards Market Performance & Indicators

Against this Challenging Backdrop, Human Albumin Study Sheds Light on
— The Human Albumin Market status quo and key characteristics. To end this, Analysts at AMA organize and took surveys of the Human Albumin industry Players. The resultant snapshot serves as a basis for understanding why and how the industry can be expected to change.
— Where Human Albumin industry is heading and what are the top priorities. Insights are drawn from financial analysis, surveys, and interviews with key executives and industry experts.
— How every company in this diverse set of Players can best navigate the emerging competition landscape and follow a strategy that helps them position to hold the value they currently claim or capture the new addressable opportunity.

Report Objectives / Segmentation Covered

By Type
  • Human Serum Albumin
  • Recombinant Serum Albumin
By Application
  • Drug Delivery
  • Therapeutics
  • Culture Media
  • Vaccine Ingredient
  • Others
By End-User
  • Pharmaceutical & Biotechnology Industries
  • Research Institutes
  • Others

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increasing Production of Immunoglobulins
      • 3.2.2. High Demand for Albumin in R&D Activities
      • 3.2.3. Increasing Plasma Collection
    • 3.3. Market Challenges
      • 3.3.1. Pricing Pressure Met By Key Players in the Market
      • 3.3.2. High Competition from Substitute Products
    • 3.4. Market Trends
      • 3.4.1. Increasing Non-Therapeutic Application of Albumin
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Human Albumin, by Type, Application, End-User and Region (value, volume and price ) (2018-2023)
    • 5.1. Introduction
    • 5.2. Global Human Albumin (Value)
      • 5.2.1. Global Human Albumin by: Type (Value)
        • 5.2.1.1. Human Serum Albumin
        • 5.2.1.2. Recombinant Serum Albumin
      • 5.2.2. Global Human Albumin by: Application (Value)
        • 5.2.2.1. Drug Delivery
        • 5.2.2.2. Therapeutics
        • 5.2.2.3. Culture Media
        • 5.2.2.4. Vaccine Ingredient
        • 5.2.2.5. Others
      • 5.2.3. Global Human Albumin by: End-User (Value)
        • 5.2.3.1. Pharmaceutical & Biotechnology Industries
        • 5.2.3.2. Research Institutes
        • 5.2.3.3. Others
      • 5.2.4. Global Human Albumin Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Taiwan
          • 5.2.4.2.6. Australia
          • 5.2.4.2.7. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
    • 5.3. Global Human Albumin (Volume)
      • 5.3.1. Global Human Albumin by: Type (Volume)
        • 5.3.1.1. Human Serum Albumin
        • 5.3.1.2. Recombinant Serum Albumin
      • 5.3.2. Global Human Albumin by: Application (Volume)
        • 5.3.2.1. Drug Delivery
        • 5.3.2.2. Therapeutics
        • 5.3.2.3. Culture Media
        • 5.3.2.4. Vaccine Ingredient
        • 5.3.2.5. Others
      • 5.3.3. Global Human Albumin by: End-User (Volume)
        • 5.3.3.1. Pharmaceutical & Biotechnology Industries
        • 5.3.3.2. Research Institutes
        • 5.3.3.3. Others
      • 5.3.4. Global Human Albumin Region
        • 5.3.4.1. South America
          • 5.3.4.1.1. Brazil
          • 5.3.4.1.2. Argentina
          • 5.3.4.1.3. Rest of South America
        • 5.3.4.2. Asia Pacific
          • 5.3.4.2.1. China
          • 5.3.4.2.2. Japan
          • 5.3.4.2.3. India
          • 5.3.4.2.4. South Korea
          • 5.3.4.2.5. Taiwan
          • 5.3.4.2.6. Australia
          • 5.3.4.2.7. Rest of Asia-Pacific
        • 5.3.4.3. Europe
          • 5.3.4.3.1. Germany
          • 5.3.4.3.2. France
          • 5.3.4.3.3. Italy
          • 5.3.4.3.4. United Kingdom
          • 5.3.4.3.5. Netherlands
          • 5.3.4.3.6. Rest of Europe
        • 5.3.4.4. MEA
          • 5.3.4.4.1. Middle East
          • 5.3.4.4.2. Africa
        • 5.3.4.5. North America
          • 5.3.4.5.1. United States
          • 5.3.4.5.2. Canada
          • 5.3.4.5.3. Mexico
    • 5.4. Global Human Albumin (Price)
      • 5.4.1. Global Human Albumin by: Type (Price)
  • 6. Human Albumin: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2023)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Octapharma AG (Switzerland)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. CSL Behring LLC (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Baxter International, Inc. (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. MedxBio Pte. Ltd. (Singapore)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Novozymes A/S. (Denmark)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Mitsubishi Tanabe Pharma Corporation (Japan)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Sigma-Aldrich Corporation (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. China Biologic Products Inc. (China)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Thermo Fisher Scientific (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. InVitria (United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Human Albumin Sale, by Type, Application, End-User and Region (value, volume and price ) (2025-2030)
    • 7.1. Introduction
    • 7.2. Global Human Albumin (Value)
      • 7.2.1. Global Human Albumin by: Type (Value)
        • 7.2.1.1. Human Serum Albumin
        • 7.2.1.2. Recombinant Serum Albumin
      • 7.2.2. Global Human Albumin by: Application (Value)
        • 7.2.2.1. Drug Delivery
        • 7.2.2.2. Therapeutics
        • 7.2.2.3. Culture Media
        • 7.2.2.4. Vaccine Ingredient
        • 7.2.2.5. Others
      • 7.2.3. Global Human Albumin by: End-User (Value)
        • 7.2.3.1. Pharmaceutical & Biotechnology Industries
        • 7.2.3.2. Research Institutes
        • 7.2.3.3. Others
      • 7.2.4. Global Human Albumin Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Taiwan
          • 7.2.4.2.6. Australia
          • 7.2.4.2.7. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
    • 7.3. Global Human Albumin (Volume)
      • 7.3.1. Global Human Albumin by: Type (Volume)
        • 7.3.1.1. Human Serum Albumin
        • 7.3.1.2. Recombinant Serum Albumin
      • 7.3.2. Global Human Albumin by: Application (Volume)
        • 7.3.2.1. Drug Delivery
        • 7.3.2.2. Therapeutics
        • 7.3.2.3. Culture Media
        • 7.3.2.4. Vaccine Ingredient
        • 7.3.2.5. Others
      • 7.3.3. Global Human Albumin by: End-User (Volume)
        • 7.3.3.1. Pharmaceutical & Biotechnology Industries
        • 7.3.3.2. Research Institutes
        • 7.3.3.3. Others
      • 7.3.4. Global Human Albumin Region
        • 7.3.4.1. South America
          • 7.3.4.1.1. Brazil
          • 7.3.4.1.2. Argentina
          • 7.3.4.1.3. Rest of South America
        • 7.3.4.2. Asia Pacific
          • 7.3.4.2.1. China
          • 7.3.4.2.2. Japan
          • 7.3.4.2.3. India
          • 7.3.4.2.4. South Korea
          • 7.3.4.2.5. Taiwan
          • 7.3.4.2.6. Australia
          • 7.3.4.2.7. Rest of Asia-Pacific
        • 7.3.4.3. Europe
          • 7.3.4.3.1. Germany
          • 7.3.4.3.2. France
          • 7.3.4.3.3. Italy
          • 7.3.4.3.4. United Kingdom
          • 7.3.4.3.5. Netherlands
          • 7.3.4.3.6. Rest of Europe
        • 7.3.4.4. MEA
          • 7.3.4.4.1. Middle East
          • 7.3.4.4.2. Africa
        • 7.3.4.5. North America
          • 7.3.4.5.1. United States
          • 7.3.4.5.2. Canada
          • 7.3.4.5.3. Mexico
    • 7.4. Global Human Albumin (Price)
      • 7.4.1. Global Human Albumin by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Human Albumin: by Type(USD Million)
  • Table 2. Human Albumin Human Serum Albumin , by Region USD Million (2018-2023)
  • Table 3. Human Albumin Recombinant Serum Albumin , by Region USD Million (2018-2023)
  • Table 4. Human Albumin: by Application(USD Million)
  • Table 5. Human Albumin Drug Delivery , by Region USD Million (2018-2023)
  • Table 6. Human Albumin Therapeutics , by Region USD Million (2018-2023)
  • Table 7. Human Albumin Culture Media , by Region USD Million (2018-2023)
  • Table 8. Human Albumin Vaccine Ingredient , by Region USD Million (2018-2023)
  • Table 9. Human Albumin Others , by Region USD Million (2018-2023)
  • Table 10. Human Albumin: by End-User(USD Million)
  • Table 11. Human Albumin Pharmaceutical & Biotechnology Industries , by Region USD Million (2018-2023)
  • Table 12. Human Albumin Research Institutes , by Region USD Million (2018-2023)
  • Table 13. Human Albumin Others , by Region USD Million (2018-2023)
  • Table 14. South America Human Albumin, by Country USD Million (2018-2023)
  • Table 15. South America Human Albumin, by Type USD Million (2018-2023)
  • Table 16. South America Human Albumin, by Application USD Million (2018-2023)
  • Table 17. South America Human Albumin, by End-User USD Million (2018-2023)
  • Table 18. Brazil Human Albumin, by Type USD Million (2018-2023)
  • Table 19. Brazil Human Albumin, by Application USD Million (2018-2023)
  • Table 20. Brazil Human Albumin, by End-User USD Million (2018-2023)
  • Table 21. Argentina Human Albumin, by Type USD Million (2018-2023)
  • Table 22. Argentina Human Albumin, by Application USD Million (2018-2023)
  • Table 23. Argentina Human Albumin, by End-User USD Million (2018-2023)
  • Table 24. Rest of South America Human Albumin, by Type USD Million (2018-2023)
  • Table 25. Rest of South America Human Albumin, by Application USD Million (2018-2023)
  • Table 26. Rest of South America Human Albumin, by End-User USD Million (2018-2023)
  • Table 27. Asia Pacific Human Albumin, by Country USD Million (2018-2023)
  • Table 28. Asia Pacific Human Albumin, by Type USD Million (2018-2023)
  • Table 29. Asia Pacific Human Albumin, by Application USD Million (2018-2023)
  • Table 30. Asia Pacific Human Albumin, by End-User USD Million (2018-2023)
  • Table 31. China Human Albumin, by Type USD Million (2018-2023)
  • Table 32. China Human Albumin, by Application USD Million (2018-2023)
  • Table 33. China Human Albumin, by End-User USD Million (2018-2023)
  • Table 34. Japan Human Albumin, by Type USD Million (2018-2023)
  • Table 35. Japan Human Albumin, by Application USD Million (2018-2023)
  • Table 36. Japan Human Albumin, by End-User USD Million (2018-2023)
  • Table 37. India Human Albumin, by Type USD Million (2018-2023)
  • Table 38. India Human Albumin, by Application USD Million (2018-2023)
  • Table 39. India Human Albumin, by End-User USD Million (2018-2023)
  • Table 40. South Korea Human Albumin, by Type USD Million (2018-2023)
  • Table 41. South Korea Human Albumin, by Application USD Million (2018-2023)
  • Table 42. South Korea Human Albumin, by End-User USD Million (2018-2023)
  • Table 43. Taiwan Human Albumin, by Type USD Million (2018-2023)
  • Table 44. Taiwan Human Albumin, by Application USD Million (2018-2023)
  • Table 45. Taiwan Human Albumin, by End-User USD Million (2018-2023)
  • Table 46. Australia Human Albumin, by Type USD Million (2018-2023)
  • Table 47. Australia Human Albumin, by Application USD Million (2018-2023)
  • Table 48. Australia Human Albumin, by End-User USD Million (2018-2023)
  • Table 49. Rest of Asia-Pacific Human Albumin, by Type USD Million (2018-2023)
  • Table 50. Rest of Asia-Pacific Human Albumin, by Application USD Million (2018-2023)
  • Table 51. Rest of Asia-Pacific Human Albumin, by End-User USD Million (2018-2023)
  • Table 52. Europe Human Albumin, by Country USD Million (2018-2023)
  • Table 53. Europe Human Albumin, by Type USD Million (2018-2023)
  • Table 54. Europe Human Albumin, by Application USD Million (2018-2023)
  • Table 55. Europe Human Albumin, by End-User USD Million (2018-2023)
  • Table 56. Germany Human Albumin, by Type USD Million (2018-2023)
  • Table 57. Germany Human Albumin, by Application USD Million (2018-2023)
  • Table 58. Germany Human Albumin, by End-User USD Million (2018-2023)
  • Table 59. France Human Albumin, by Type USD Million (2018-2023)
  • Table 60. France Human Albumin, by Application USD Million (2018-2023)
  • Table 61. France Human Albumin, by End-User USD Million (2018-2023)
  • Table 62. Italy Human Albumin, by Type USD Million (2018-2023)
  • Table 63. Italy Human Albumin, by Application USD Million (2018-2023)
  • Table 64. Italy Human Albumin, by End-User USD Million (2018-2023)
  • Table 65. United Kingdom Human Albumin, by Type USD Million (2018-2023)
  • Table 66. United Kingdom Human Albumin, by Application USD Million (2018-2023)
  • Table 67. United Kingdom Human Albumin, by End-User USD Million (2018-2023)
  • Table 68. Netherlands Human Albumin, by Type USD Million (2018-2023)
  • Table 69. Netherlands Human Albumin, by Application USD Million (2018-2023)
  • Table 70. Netherlands Human Albumin, by End-User USD Million (2018-2023)
  • Table 71. Rest of Europe Human Albumin, by Type USD Million (2018-2023)
  • Table 72. Rest of Europe Human Albumin, by Application USD Million (2018-2023)
  • Table 73. Rest of Europe Human Albumin, by End-User USD Million (2018-2023)
  • Table 74. MEA Human Albumin, by Country USD Million (2018-2023)
  • Table 75. MEA Human Albumin, by Type USD Million (2018-2023)
  • Table 76. MEA Human Albumin, by Application USD Million (2018-2023)
  • Table 77. MEA Human Albumin, by End-User USD Million (2018-2023)
  • Table 78. Middle East Human Albumin, by Type USD Million (2018-2023)
  • Table 79. Middle East Human Albumin, by Application USD Million (2018-2023)
  • Table 80. Middle East Human Albumin, by End-User USD Million (2018-2023)
  • Table 81. Africa Human Albumin, by Type USD Million (2018-2023)
  • Table 82. Africa Human Albumin, by Application USD Million (2018-2023)
  • Table 83. Africa Human Albumin, by End-User USD Million (2018-2023)
  • Table 84. North America Human Albumin, by Country USD Million (2018-2023)
  • Table 85. North America Human Albumin, by Type USD Million (2018-2023)
  • Table 86. North America Human Albumin, by Application USD Million (2018-2023)
  • Table 87. North America Human Albumin, by End-User USD Million (2018-2023)
  • Table 88. United States Human Albumin, by Type USD Million (2018-2023)
  • Table 89. United States Human Albumin, by Application USD Million (2018-2023)
  • Table 90. United States Human Albumin, by End-User USD Million (2018-2023)
  • Table 91. Canada Human Albumin, by Type USD Million (2018-2023)
  • Table 92. Canada Human Albumin, by Application USD Million (2018-2023)
  • Table 93. Canada Human Albumin, by End-User USD Million (2018-2023)
  • Table 94. Mexico Human Albumin, by Type USD Million (2018-2023)
  • Table 95. Mexico Human Albumin, by Application USD Million (2018-2023)
  • Table 96. Mexico Human Albumin, by End-User USD Million (2018-2023)
  • Table 97. Human Albumin Sales: by Type(mL)
  • Table 98. Human Albumin Sales Human Serum Albumin , by Region mL (2018-2023)
  • Table 99. Human Albumin Sales Recombinant Serum Albumin , by Region mL (2018-2023)
  • Table 100. Human Albumin Sales: by Application(mL)
  • Table 101. Human Albumin Sales Drug Delivery , by Region mL (2018-2023)
  • Table 102. Human Albumin Sales Therapeutics , by Region mL (2018-2023)
  • Table 103. Human Albumin Sales Culture Media , by Region mL (2018-2023)
  • Table 104. Human Albumin Sales Vaccine Ingredient , by Region mL (2018-2023)
  • Table 105. Human Albumin Sales Others , by Region mL (2018-2023)
  • Table 106. Human Albumin Sales: by End-User(mL)
  • Table 107. Human Albumin Sales Pharmaceutical & Biotechnology Industries , by Region mL (2018-2023)
  • Table 108. Human Albumin Sales Research Institutes , by Region mL (2018-2023)
  • Table 109. Human Albumin Sales Others , by Region mL (2018-2023)
  • Table 110. South America Human Albumin Sales, by Country mL (2018-2023)
  • Table 111. South America Human Albumin Sales, by Type mL (2018-2023)
  • Table 112. South America Human Albumin Sales, by Application mL (2018-2023)
  • Table 113. South America Human Albumin Sales, by End-User mL (2018-2023)
  • Table 114. Brazil Human Albumin Sales, by Type mL (2018-2023)
  • Table 115. Brazil Human Albumin Sales, by Application mL (2018-2023)
  • Table 116. Brazil Human Albumin Sales, by End-User mL (2018-2023)
  • Table 117. Argentina Human Albumin Sales, by Type mL (2018-2023)
  • Table 118. Argentina Human Albumin Sales, by Application mL (2018-2023)
  • Table 119. Argentina Human Albumin Sales, by End-User mL (2018-2023)
  • Table 120. Rest of South America Human Albumin Sales, by Type mL (2018-2023)
  • Table 121. Rest of South America Human Albumin Sales, by Application mL (2018-2023)
  • Table 122. Rest of South America Human Albumin Sales, by End-User mL (2018-2023)
  • Table 123. Asia Pacific Human Albumin Sales, by Country mL (2018-2023)
  • Table 124. Asia Pacific Human Albumin Sales, by Type mL (2018-2023)
  • Table 125. Asia Pacific Human Albumin Sales, by Application mL (2018-2023)
  • Table 126. Asia Pacific Human Albumin Sales, by End-User mL (2018-2023)
  • Table 127. China Human Albumin Sales, by Type mL (2018-2023)
  • Table 128. China Human Albumin Sales, by Application mL (2018-2023)
  • Table 129. China Human Albumin Sales, by End-User mL (2018-2023)
  • Table 130. Japan Human Albumin Sales, by Type mL (2018-2023)
  • Table 131. Japan Human Albumin Sales, by Application mL (2018-2023)
  • Table 132. Japan Human Albumin Sales, by End-User mL (2018-2023)
  • Table 133. India Human Albumin Sales, by Type mL (2018-2023)
  • Table 134. India Human Albumin Sales, by Application mL (2018-2023)
  • Table 135. India Human Albumin Sales, by End-User mL (2018-2023)
  • Table 136. South Korea Human Albumin Sales, by Type mL (2018-2023)
  • Table 137. South Korea Human Albumin Sales, by Application mL (2018-2023)
  • Table 138. South Korea Human Albumin Sales, by End-User mL (2018-2023)
  • Table 139. Taiwan Human Albumin Sales, by Type mL (2018-2023)
  • Table 140. Taiwan Human Albumin Sales, by Application mL (2018-2023)
  • Table 141. Taiwan Human Albumin Sales, by End-User mL (2018-2023)
  • Table 142. Australia Human Albumin Sales, by Type mL (2018-2023)
  • Table 143. Australia Human Albumin Sales, by Application mL (2018-2023)
  • Table 144. Australia Human Albumin Sales, by End-User mL (2018-2023)
  • Table 145. Rest of Asia-Pacific Human Albumin Sales, by Type mL (2018-2023)
  • Table 146. Rest of Asia-Pacific Human Albumin Sales, by Application mL (2018-2023)
  • Table 147. Rest of Asia-Pacific Human Albumin Sales, by End-User mL (2018-2023)
  • Table 148. Europe Human Albumin Sales, by Country mL (2018-2023)
  • Table 149. Europe Human Albumin Sales, by Type mL (2018-2023)
  • Table 150. Europe Human Albumin Sales, by Application mL (2018-2023)
  • Table 151. Europe Human Albumin Sales, by End-User mL (2018-2023)
  • Table 152. Germany Human Albumin Sales, by Type mL (2018-2023)
  • Table 153. Germany Human Albumin Sales, by Application mL (2018-2023)
  • Table 154. Germany Human Albumin Sales, by End-User mL (2018-2023)
  • Table 155. France Human Albumin Sales, by Type mL (2018-2023)
  • Table 156. France Human Albumin Sales, by Application mL (2018-2023)
  • Table 157. France Human Albumin Sales, by End-User mL (2018-2023)
  • Table 158. Italy Human Albumin Sales, by Type mL (2018-2023)
  • Table 159. Italy Human Albumin Sales, by Application mL (2018-2023)
  • Table 160. Italy Human Albumin Sales, by End-User mL (2018-2023)
  • Table 161. United Kingdom Human Albumin Sales, by Type mL (2018-2023)
  • Table 162. United Kingdom Human Albumin Sales, by Application mL (2018-2023)
  • Table 163. United Kingdom Human Albumin Sales, by End-User mL (2018-2023)
  • Table 164. Netherlands Human Albumin Sales, by Type mL (2018-2023)
  • Table 165. Netherlands Human Albumin Sales, by Application mL (2018-2023)
  • Table 166. Netherlands Human Albumin Sales, by End-User mL (2018-2023)
  • Table 167. Rest of Europe Human Albumin Sales, by Type mL (2018-2023)
  • Table 168. Rest of Europe Human Albumin Sales, by Application mL (2018-2023)
  • Table 169. Rest of Europe Human Albumin Sales, by End-User mL (2018-2023)
  • Table 170. MEA Human Albumin Sales, by Country mL (2018-2023)
  • Table 171. MEA Human Albumin Sales, by Type mL (2018-2023)
  • Table 172. MEA Human Albumin Sales, by Application mL (2018-2023)
  • Table 173. MEA Human Albumin Sales, by End-User mL (2018-2023)
  • Table 174. Middle East Human Albumin Sales, by Type mL (2018-2023)
  • Table 175. Middle East Human Albumin Sales, by Application mL (2018-2023)
  • Table 176. Middle East Human Albumin Sales, by End-User mL (2018-2023)
  • Table 177. Africa Human Albumin Sales, by Type mL (2018-2023)
  • Table 178. Africa Human Albumin Sales, by Application mL (2018-2023)
  • Table 179. Africa Human Albumin Sales, by End-User mL (2018-2023)
  • Table 180. North America Human Albumin Sales, by Country mL (2018-2023)
  • Table 181. North America Human Albumin Sales, by Type mL (2018-2023)
  • Table 182. North America Human Albumin Sales, by Application mL (2018-2023)
  • Table 183. North America Human Albumin Sales, by End-User mL (2018-2023)
  • Table 184. United States Human Albumin Sales, by Type mL (2018-2023)
  • Table 185. United States Human Albumin Sales, by Application mL (2018-2023)
  • Table 186. United States Human Albumin Sales, by End-User mL (2018-2023)
  • Table 187. Canada Human Albumin Sales, by Type mL (2018-2023)
  • Table 188. Canada Human Albumin Sales, by Application mL (2018-2023)
  • Table 189. Canada Human Albumin Sales, by End-User mL (2018-2023)
  • Table 190. Mexico Human Albumin Sales, by Type mL (2018-2023)
  • Table 191. Mexico Human Albumin Sales, by Application mL (2018-2023)
  • Table 192. Mexico Human Albumin Sales, by End-User mL (2018-2023)
  • Table 193. Human Albumin: by Type(USD/Units)
  • Table 194. Company Basic Information, Sales Area and Its Competitors
  • Table 195. Company Basic Information, Sales Area and Its Competitors
  • Table 196. Company Basic Information, Sales Area and Its Competitors
  • Table 197. Company Basic Information, Sales Area and Its Competitors
  • Table 198. Company Basic Information, Sales Area and Its Competitors
  • Table 199. Company Basic Information, Sales Area and Its Competitors
  • Table 200. Company Basic Information, Sales Area and Its Competitors
  • Table 201. Company Basic Information, Sales Area and Its Competitors
  • Table 202. Company Basic Information, Sales Area and Its Competitors
  • Table 203. Company Basic Information, Sales Area and Its Competitors
  • Table 204. Human Albumin: by Type(USD Million)
  • Table 205. Human Albumin Human Serum Albumin , by Region USD Million (2025-2030)
  • Table 206. Human Albumin Recombinant Serum Albumin , by Region USD Million (2025-2030)
  • Table 207. Human Albumin: by Application(USD Million)
  • Table 208. Human Albumin Drug Delivery , by Region USD Million (2025-2030)
  • Table 209. Human Albumin Therapeutics , by Region USD Million (2025-2030)
  • Table 210. Human Albumin Culture Media , by Region USD Million (2025-2030)
  • Table 211. Human Albumin Vaccine Ingredient , by Region USD Million (2025-2030)
  • Table 212. Human Albumin Others , by Region USD Million (2025-2030)
  • Table 213. Human Albumin: by End-User(USD Million)
  • Table 214. Human Albumin Pharmaceutical & Biotechnology Industries , by Region USD Million (2025-2030)
  • Table 215. Human Albumin Research Institutes , by Region USD Million (2025-2030)
  • Table 216. Human Albumin Others , by Region USD Million (2025-2030)
  • Table 217. South America Human Albumin, by Country USD Million (2025-2030)
  • Table 218. South America Human Albumin, by Type USD Million (2025-2030)
  • Table 219. South America Human Albumin, by Application USD Million (2025-2030)
  • Table 220. South America Human Albumin, by End-User USD Million (2025-2030)
  • Table 221. Brazil Human Albumin, by Type USD Million (2025-2030)
  • Table 222. Brazil Human Albumin, by Application USD Million (2025-2030)
  • Table 223. Brazil Human Albumin, by End-User USD Million (2025-2030)
  • Table 224. Argentina Human Albumin, by Type USD Million (2025-2030)
  • Table 225. Argentina Human Albumin, by Application USD Million (2025-2030)
  • Table 226. Argentina Human Albumin, by End-User USD Million (2025-2030)
  • Table 227. Rest of South America Human Albumin, by Type USD Million (2025-2030)
  • Table 228. Rest of South America Human Albumin, by Application USD Million (2025-2030)
  • Table 229. Rest of South America Human Albumin, by End-User USD Million (2025-2030)
  • Table 230. Asia Pacific Human Albumin, by Country USD Million (2025-2030)
  • Table 231. Asia Pacific Human Albumin, by Type USD Million (2025-2030)
  • Table 232. Asia Pacific Human Albumin, by Application USD Million (2025-2030)
  • Table 233. Asia Pacific Human Albumin, by End-User USD Million (2025-2030)
  • Table 234. China Human Albumin, by Type USD Million (2025-2030)
  • Table 235. China Human Albumin, by Application USD Million (2025-2030)
  • Table 236. China Human Albumin, by End-User USD Million (2025-2030)
  • Table 237. Japan Human Albumin, by Type USD Million (2025-2030)
  • Table 238. Japan Human Albumin, by Application USD Million (2025-2030)
  • Table 239. Japan Human Albumin, by End-User USD Million (2025-2030)
  • Table 240. India Human Albumin, by Type USD Million (2025-2030)
  • Table 241. India Human Albumin, by Application USD Million (2025-2030)
  • Table 242. India Human Albumin, by End-User USD Million (2025-2030)
  • Table 243. South Korea Human Albumin, by Type USD Million (2025-2030)
  • Table 244. South Korea Human Albumin, by Application USD Million (2025-2030)
  • Table 245. South Korea Human Albumin, by End-User USD Million (2025-2030)
  • Table 246. Taiwan Human Albumin, by Type USD Million (2025-2030)
  • Table 247. Taiwan Human Albumin, by Application USD Million (2025-2030)
  • Table 248. Taiwan Human Albumin, by End-User USD Million (2025-2030)
  • Table 249. Australia Human Albumin, by Type USD Million (2025-2030)
  • Table 250. Australia Human Albumin, by Application USD Million (2025-2030)
  • Table 251. Australia Human Albumin, by End-User USD Million (2025-2030)
  • Table 252. Rest of Asia-Pacific Human Albumin, by Type USD Million (2025-2030)
  • Table 253. Rest of Asia-Pacific Human Albumin, by Application USD Million (2025-2030)
  • Table 254. Rest of Asia-Pacific Human Albumin, by End-User USD Million (2025-2030)
  • Table 255. Europe Human Albumin, by Country USD Million (2025-2030)
  • Table 256. Europe Human Albumin, by Type USD Million (2025-2030)
  • Table 257. Europe Human Albumin, by Application USD Million (2025-2030)
  • Table 258. Europe Human Albumin, by End-User USD Million (2025-2030)
  • Table 259. Germany Human Albumin, by Type USD Million (2025-2030)
  • Table 260. Germany Human Albumin, by Application USD Million (2025-2030)
  • Table 261. Germany Human Albumin, by End-User USD Million (2025-2030)
  • Table 262. France Human Albumin, by Type USD Million (2025-2030)
  • Table 263. France Human Albumin, by Application USD Million (2025-2030)
  • Table 264. France Human Albumin, by End-User USD Million (2025-2030)
  • Table 265. Italy Human Albumin, by Type USD Million (2025-2030)
  • Table 266. Italy Human Albumin, by Application USD Million (2025-2030)
  • Table 267. Italy Human Albumin, by End-User USD Million (2025-2030)
  • Table 268. United Kingdom Human Albumin, by Type USD Million (2025-2030)
  • Table 269. United Kingdom Human Albumin, by Application USD Million (2025-2030)
  • Table 270. United Kingdom Human Albumin, by End-User USD Million (2025-2030)
  • Table 271. Netherlands Human Albumin, by Type USD Million (2025-2030)
  • Table 272. Netherlands Human Albumin, by Application USD Million (2025-2030)
  • Table 273. Netherlands Human Albumin, by End-User USD Million (2025-2030)
  • Table 274. Rest of Europe Human Albumin, by Type USD Million (2025-2030)
  • Table 275. Rest of Europe Human Albumin, by Application USD Million (2025-2030)
  • Table 276. Rest of Europe Human Albumin, by End-User USD Million (2025-2030)
  • Table 277. MEA Human Albumin, by Country USD Million (2025-2030)
  • Table 278. MEA Human Albumin, by Type USD Million (2025-2030)
  • Table 279. MEA Human Albumin, by Application USD Million (2025-2030)
  • Table 280. MEA Human Albumin, by End-User USD Million (2025-2030)
  • Table 281. Middle East Human Albumin, by Type USD Million (2025-2030)
  • Table 282. Middle East Human Albumin, by Application USD Million (2025-2030)
  • Table 283. Middle East Human Albumin, by End-User USD Million (2025-2030)
  • Table 284. Africa Human Albumin, by Type USD Million (2025-2030)
  • Table 285. Africa Human Albumin, by Application USD Million (2025-2030)
  • Table 286. Africa Human Albumin, by End-User USD Million (2025-2030)
  • Table 287. North America Human Albumin, by Country USD Million (2025-2030)
  • Table 288. North America Human Albumin, by Type USD Million (2025-2030)
  • Table 289. North America Human Albumin, by Application USD Million (2025-2030)
  • Table 290. North America Human Albumin, by End-User USD Million (2025-2030)
  • Table 291. United States Human Albumin, by Type USD Million (2025-2030)
  • Table 292. United States Human Albumin, by Application USD Million (2025-2030)
  • Table 293. United States Human Albumin, by End-User USD Million (2025-2030)
  • Table 294. Canada Human Albumin, by Type USD Million (2025-2030)
  • Table 295. Canada Human Albumin, by Application USD Million (2025-2030)
  • Table 296. Canada Human Albumin, by End-User USD Million (2025-2030)
  • Table 297. Mexico Human Albumin, by Type USD Million (2025-2030)
  • Table 298. Mexico Human Albumin, by Application USD Million (2025-2030)
  • Table 299. Mexico Human Albumin, by End-User USD Million (2025-2030)
  • Table 300. Human Albumin Sales: by Type(mL)
  • Table 301. Human Albumin Sales Human Serum Albumin , by Region mL (2025-2030)
  • Table 302. Human Albumin Sales Recombinant Serum Albumin , by Region mL (2025-2030)
  • Table 303. Human Albumin Sales: by Application(mL)
  • Table 304. Human Albumin Sales Drug Delivery , by Region mL (2025-2030)
  • Table 305. Human Albumin Sales Therapeutics , by Region mL (2025-2030)
  • Table 306. Human Albumin Sales Culture Media , by Region mL (2025-2030)
  • Table 307. Human Albumin Sales Vaccine Ingredient , by Region mL (2025-2030)
  • Table 308. Human Albumin Sales Others , by Region mL (2025-2030)
  • Table 309. Human Albumin Sales: by End-User(mL)
  • Table 310. Human Albumin Sales Pharmaceutical & Biotechnology Industries , by Region mL (2025-2030)
  • Table 311. Human Albumin Sales Research Institutes , by Region mL (2025-2030)
  • Table 312. Human Albumin Sales Others , by Region mL (2025-2030)
  • Table 313. South America Human Albumin Sales, by Country mL (2025-2030)
  • Table 314. South America Human Albumin Sales, by Type mL (2025-2030)
  • Table 315. South America Human Albumin Sales, by Application mL (2025-2030)
  • Table 316. South America Human Albumin Sales, by End-User mL (2025-2030)
  • Table 317. Brazil Human Albumin Sales, by Type mL (2025-2030)
  • Table 318. Brazil Human Albumin Sales, by Application mL (2025-2030)
  • Table 319. Brazil Human Albumin Sales, by End-User mL (2025-2030)
  • Table 320. Argentina Human Albumin Sales, by Type mL (2025-2030)
  • Table 321. Argentina Human Albumin Sales, by Application mL (2025-2030)
  • Table 322. Argentina Human Albumin Sales, by End-User mL (2025-2030)
  • Table 323. Rest of South America Human Albumin Sales, by Type mL (2025-2030)
  • Table 324. Rest of South America Human Albumin Sales, by Application mL (2025-2030)
  • Table 325. Rest of South America Human Albumin Sales, by End-User mL (2025-2030)
  • Table 326. Asia Pacific Human Albumin Sales, by Country mL (2025-2030)
  • Table 327. Asia Pacific Human Albumin Sales, by Type mL (2025-2030)
  • Table 328. Asia Pacific Human Albumin Sales, by Application mL (2025-2030)
  • Table 329. Asia Pacific Human Albumin Sales, by End-User mL (2025-2030)
  • Table 330. China Human Albumin Sales, by Type mL (2025-2030)
  • Table 331. China Human Albumin Sales, by Application mL (2025-2030)
  • Table 332. China Human Albumin Sales, by End-User mL (2025-2030)
  • Table 333. Japan Human Albumin Sales, by Type mL (2025-2030)
  • Table 334. Japan Human Albumin Sales, by Application mL (2025-2030)
  • Table 335. Japan Human Albumin Sales, by End-User mL (2025-2030)
  • Table 336. India Human Albumin Sales, by Type mL (2025-2030)
  • Table 337. India Human Albumin Sales, by Application mL (2025-2030)
  • Table 338. India Human Albumin Sales, by End-User mL (2025-2030)
  • Table 339. South Korea Human Albumin Sales, by Type mL (2025-2030)
  • Table 340. South Korea Human Albumin Sales, by Application mL (2025-2030)
  • Table 341. South Korea Human Albumin Sales, by End-User mL (2025-2030)
  • Table 342. Taiwan Human Albumin Sales, by Type mL (2025-2030)
  • Table 343. Taiwan Human Albumin Sales, by Application mL (2025-2030)
  • Table 344. Taiwan Human Albumin Sales, by End-User mL (2025-2030)
  • Table 345. Australia Human Albumin Sales, by Type mL (2025-2030)
  • Table 346. Australia Human Albumin Sales, by Application mL (2025-2030)
  • Table 347. Australia Human Albumin Sales, by End-User mL (2025-2030)
  • Table 348. Rest of Asia-Pacific Human Albumin Sales, by Type mL (2025-2030)
  • Table 349. Rest of Asia-Pacific Human Albumin Sales, by Application mL (2025-2030)
  • Table 350. Rest of Asia-Pacific Human Albumin Sales, by End-User mL (2025-2030)
  • Table 351. Europe Human Albumin Sales, by Country mL (2025-2030)
  • Table 352. Europe Human Albumin Sales, by Type mL (2025-2030)
  • Table 353. Europe Human Albumin Sales, by Application mL (2025-2030)
  • Table 354. Europe Human Albumin Sales, by End-User mL (2025-2030)
  • Table 355. Germany Human Albumin Sales, by Type mL (2025-2030)
  • Table 356. Germany Human Albumin Sales, by Application mL (2025-2030)
  • Table 357. Germany Human Albumin Sales, by End-User mL (2025-2030)
  • Table 358. France Human Albumin Sales, by Type mL (2025-2030)
  • Table 359. France Human Albumin Sales, by Application mL (2025-2030)
  • Table 360. France Human Albumin Sales, by End-User mL (2025-2030)
  • Table 361. Italy Human Albumin Sales, by Type mL (2025-2030)
  • Table 362. Italy Human Albumin Sales, by Application mL (2025-2030)
  • Table 363. Italy Human Albumin Sales, by End-User mL (2025-2030)
  • Table 364. United Kingdom Human Albumin Sales, by Type mL (2025-2030)
  • Table 365. United Kingdom Human Albumin Sales, by Application mL (2025-2030)
  • Table 366. United Kingdom Human Albumin Sales, by End-User mL (2025-2030)
  • Table 367. Netherlands Human Albumin Sales, by Type mL (2025-2030)
  • Table 368. Netherlands Human Albumin Sales, by Application mL (2025-2030)
  • Table 369. Netherlands Human Albumin Sales, by End-User mL (2025-2030)
  • Table 370. Rest of Europe Human Albumin Sales, by Type mL (2025-2030)
  • Table 371. Rest of Europe Human Albumin Sales, by Application mL (2025-2030)
  • Table 372. Rest of Europe Human Albumin Sales, by End-User mL (2025-2030)
  • Table 373. MEA Human Albumin Sales, by Country mL (2025-2030)
  • Table 374. MEA Human Albumin Sales, by Type mL (2025-2030)
  • Table 375. MEA Human Albumin Sales, by Application mL (2025-2030)
  • Table 376. MEA Human Albumin Sales, by End-User mL (2025-2030)
  • Table 377. Middle East Human Albumin Sales, by Type mL (2025-2030)
  • Table 378. Middle East Human Albumin Sales, by Application mL (2025-2030)
  • Table 379. Middle East Human Albumin Sales, by End-User mL (2025-2030)
  • Table 380. Africa Human Albumin Sales, by Type mL (2025-2030)
  • Table 381. Africa Human Albumin Sales, by Application mL (2025-2030)
  • Table 382. Africa Human Albumin Sales, by End-User mL (2025-2030)
  • Table 383. North America Human Albumin Sales, by Country mL (2025-2030)
  • Table 384. North America Human Albumin Sales, by Type mL (2025-2030)
  • Table 385. North America Human Albumin Sales, by Application mL (2025-2030)
  • Table 386. North America Human Albumin Sales, by End-User mL (2025-2030)
  • Table 387. United States Human Albumin Sales, by Type mL (2025-2030)
  • Table 388. United States Human Albumin Sales, by Application mL (2025-2030)
  • Table 389. United States Human Albumin Sales, by End-User mL (2025-2030)
  • Table 390. Canada Human Albumin Sales, by Type mL (2025-2030)
  • Table 391. Canada Human Albumin Sales, by Application mL (2025-2030)
  • Table 392. Canada Human Albumin Sales, by End-User mL (2025-2030)
  • Table 393. Mexico Human Albumin Sales, by Type mL (2025-2030)
  • Table 394. Mexico Human Albumin Sales, by Application mL (2025-2030)
  • Table 395. Mexico Human Albumin Sales, by End-User mL (2025-2030)
  • Table 396. Human Albumin: by Type(USD/Units)
  • Table 397. Research Programs/Design for This Report
  • Table 398. Key Data Information from Secondary Sources
  • Table 399. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Human Albumin: by Type USD Million (2018-2023)
  • Figure 5. Global Human Albumin: by Application USD Million (2018-2023)
  • Figure 6. Global Human Albumin: by End-User USD Million (2018-2023)
  • Figure 7. South America Human Albumin Share (%), by Country
  • Figure 8. Asia Pacific Human Albumin Share (%), by Country
  • Figure 9. Europe Human Albumin Share (%), by Country
  • Figure 10. MEA Human Albumin Share (%), by Country
  • Figure 11. North America Human Albumin Share (%), by Country
  • Figure 12. Global Human Albumin: by Type mL (2018-2023)
  • Figure 13. Global Human Albumin: by Application mL (2018-2023)
  • Figure 14. Global Human Albumin: by End-User mL (2018-2023)
  • Figure 15. South America Human Albumin Share (%), by Country
  • Figure 16. Asia Pacific Human Albumin Share (%), by Country
  • Figure 17. Europe Human Albumin Share (%), by Country
  • Figure 18. MEA Human Albumin Share (%), by Country
  • Figure 19. North America Human Albumin Share (%), by Country
  • Figure 20. Global Human Albumin: by Type USD/Units (2018-2023)
  • Figure 21. Global Human Albumin share by Players 2023 (%)
  • Figure 22. Global Human Albumin share by Players (Top 3) 2023(%)
  • Figure 23. Global Human Albumin share by Players (Top 5) 2023(%)
  • Figure 24. BCG Matrix for key Companies
  • Figure 25. Octapharma AG (Switzerland) Revenue, Net Income and Gross profit
  • Figure 26. Octapharma AG (Switzerland) Revenue: by Geography 2023
  • Figure 27. CSL Behring LLC (United States) Revenue, Net Income and Gross profit
  • Figure 28. CSL Behring LLC (United States) Revenue: by Geography 2023
  • Figure 29. Baxter International, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 30. Baxter International, Inc. (United States) Revenue: by Geography 2023
  • Figure 31. MedxBio Pte. Ltd. (Singapore) Revenue, Net Income and Gross profit
  • Figure 32. MedxBio Pte. Ltd. (Singapore) Revenue: by Geography 2023
  • Figure 33. Novozymes A/S. (Denmark) Revenue, Net Income and Gross profit
  • Figure 34. Novozymes A/S. (Denmark) Revenue: by Geography 2023
  • Figure 35. Mitsubishi Tanabe Pharma Corporation (Japan) Revenue, Net Income and Gross profit
  • Figure 36. Mitsubishi Tanabe Pharma Corporation (Japan) Revenue: by Geography 2023
  • Figure 37. Sigma-Aldrich Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 38. Sigma-Aldrich Corporation (United States) Revenue: by Geography 2023
  • Figure 39. China Biologic Products Inc. (China) Revenue, Net Income and Gross profit
  • Figure 40. China Biologic Products Inc. (China) Revenue: by Geography 2023
  • Figure 41. Thermo Fisher Scientific (United States) Revenue, Net Income and Gross profit
  • Figure 42. Thermo Fisher Scientific (United States) Revenue: by Geography 2023
  • Figure 43. InVitria (United States) Revenue, Net Income and Gross profit
  • Figure 44. InVitria (United States) Revenue: by Geography 2023
  • Figure 45. Global Human Albumin: by Type USD Million (2025-2030)
  • Figure 46. Global Human Albumin: by Application USD Million (2025-2030)
  • Figure 47. Global Human Albumin: by End-User USD Million (2025-2030)
  • Figure 48. South America Human Albumin Share (%), by Country
  • Figure 49. Asia Pacific Human Albumin Share (%), by Country
  • Figure 50. Europe Human Albumin Share (%), by Country
  • Figure 51. MEA Human Albumin Share (%), by Country
  • Figure 52. North America Human Albumin Share (%), by Country
  • Figure 53. Global Human Albumin: by Type mL (2025-2030)
  • Figure 54. Global Human Albumin: by Application mL (2025-2030)
  • Figure 55. Global Human Albumin: by End-User mL (2025-2030)
  • Figure 56. South America Human Albumin Share (%), by Country
  • Figure 57. Asia Pacific Human Albumin Share (%), by Country
  • Figure 58. Europe Human Albumin Share (%), by Country
  • Figure 59. MEA Human Albumin Share (%), by Country
  • Figure 60. North America Human Albumin Share (%), by Country
  • Figure 61. Global Human Albumin: by Type USD/Units (2025-2030)
List of companies from research coverage that are profiled in the study
  • Octapharma AG (Switzerland)
  • CSL Behring LLC (United States)
  • Baxter International, Inc. (United States)
  • MedxBio Pte. Ltd. (Singapore)
  • Novozymes A/S. (Denmark)
  • Mitsubishi Tanabe Pharma Corporation (Japan)
  • Sigma-Aldrich Corporation (United States)
  • China Biologic Products Inc. (China)
  • Thermo Fisher Scientific (United States)
  • InVitria (United States)
Additional players considered in the study are as follows:
Hualan Biological Engineering Inc. (China) , Takeda Pharmaceutical Company (Japan) , Beijing Tiantan Biological Products Co., Ltd.(China)
Select User Access Type

Key Highlights of Report


Mar 2024 207 Pages 82 Tables Base Year: 2023 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Human Albumin research Quantitative research analysis
Global Human Albumin research Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

Top performing companies in the Global Human Albumin market are Octapharma AG (Switzerland), CSL Behring LLC (United States), Baxter International, Inc. (United States), MedxBio Pte. Ltd. (Singapore), Novozymes A/S. (Denmark), Mitsubishi Tanabe Pharma Corporation (Japan), Sigma-Aldrich Corporation (United States), China Biologic Products Inc. (China), Thermo Fisher Scientific (United States) and InVitria (United States), to name a few.
Asia-Pacific is dominating the Human Albumin Market.
"Pricing Pressure Met By Key Players in the Market " is seen as one of the major challenges by many Industry Players of Human Albumin Market
The Human Albumin market study includes a random mix of players, including both market leaders and some top growing emerging players. Connect with our sales executive to get complete companies available in our research coverage.
The Human Albumin market is expected to see a steady growth rate during projected year 2023 to 2030.

Know More About Global Human Albumin research Report?

Have a Query? Click Here

Other Related Reports

Pyrolysis Gasoline Comprehensive Study by Type (Raw Pyrolysis Gasoline, Hydrogenated Pyrolysis Gasoline), Application (Aromatics Extraction, Refinery Feedstock, Fractionation for Benzene, Others), En...
$ 3450
Pharmaceutical Gelatin Comprehensive Study by Application (Hard Capsules, Soft Capsules, Micro-encapsulation, Coating for Tablets, Absorbable Hemostat), Function (Stabilizers, Thickeners, Gelling Age...
$ 3450
Sunitinib Malate Comprehensive Study by Application (Kidney Cancer, Pancreas Cancer, Intestinal Cancer), Distribution Channel (Hospital Pharmacy, Retail Drug Stores), Dosage (12.5mg, 25mg, 37.5mg, 50...
$ 3650
Nutraceutical Excipients Comprehensive Study by Type (Lubricants\Prebiotics, Probiotics, Proteins & Amino Acids, Vitamins & Minerals, Omega-3 Fatty Acids), Function (Binders, Fillers & diluents, Disi...
$ 3650
Paclitaxel Injection Comprehensive Study by Application (Ovarian cancer, Breast cancer, Cervical cancer, Pancreatic cancer, Other), Strength (30 mg (5 mL), 100 mg (16.7 mL), 300 mg (50 mL)), End User...
$ 3350
Primary Hyperoxaluria Drug Comprehensive Study by Type (ALLN-230, DCR-PHXC, ALN-GO1, Others), Application (Hospital, Clinic, Others), Drug types (Primary hyperoxaluria type III (PH III), Primary hype...
$ 3450